Protagenic Therapeutics Inc.

We have created a portfolio of novel neuropeptides that are being evaluated for the treatment of stress-related disorders.

[Protagenic Therapeutics Inc. @protagenic]

Register Now: Protagenic Therapeutics, Inc. (#PTIX) to Host Virtual Science Review Wednesday, Sep 8th at 10 AM ET
The focus will be a scientific review of its programs designed for the treatment of patients with Depression, PTSD, Anxiety and Addiction
https://t.co/ELwnX6ZSKU

[Protagenic Therapeutics Inc. @protagenic]

Protagenic Therapeutics, Inc. (#PTIX) Virtual Science Review:
A review of our programs designed for the treatment of patients with Depression, PTSD, Anxiety & Addiction
Watch the full webinar here: https://t.co/2MWQrJxHXH

[Protagenic Therapeutics Inc. @protagenic]

Protagenic's CMO, Bob Stein, MD, PhD is participating in the Advances in Mental Health Virtual Conference, presented by @maximgrp, hosted by @mvestllc, on Sept. 22nd, 9am – 2 pm ET.

This conference will be live on M-Vest. To attend, sign up to become an M-Vest member

[Protagenic Therapeutics Inc. @protagenic]

@dhno28 Thank you!

[Protagenic Therapeutics Inc. @protagenic]

Pioneering Neuronal Health: Aiming to be an innovative, safe, and effective treatment platform that regulates stress response and restores healthy brain function.

Introducing the brand new Protagenic Website:
https://t.co/JGXCRylrmw

[Protagenic Therapeutics Inc. @protagenic]

A recent investor forum with Q&A featuring Dr. Maurizio Fava, principal investigator of the planned PT00114 Phase I/IIa clinical trial, is now available for viewing here: https://t.co/eg9f3jLmBM

[Protagenic Therapeutics Inc. @protagenic]

Register now: Protagenic Therapeutics, Inc. (PTIX) is hosting a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction on Tuesday, July 13 at 10:00AM ET.
Register here: https://t.co/eg9f3jLmBM